Alazocine

(1R,9R,13R)-10-Allyl-1,13-dimethyl-10-azatricyclo[7.3.1.0~2,7~]trideca-2,4,6-trien-4-ol

(1R,9R,13R)-10-Allyl-1,13-dimethyl-10-azatricyclo[7.3.1.0~2,7~]trideca-2,4,6-trien-4-ol

(1R,9R,13R)-10-Allyl-1,13-diméthyl-10-azatricyclo[7.3.1.0~2,7~]tridéca-2,4,6-trién-4-ol

(2R,11R)-6,11-dimethyl-3-(prop-2-en-1-yl)-1,2,3,4,5,6-hexahydro-2,6-methano-3-benzazocin-8-ol

(2R,6R,11R)-1,2,3,4,5,6-Hexahydro-6,11-dimethyl-3-(2-propen-1-yl)-2,6-methano-3-benzazocin-8-ol

(−)-ANMC

(−)-N-allylnormetazocine

(−)-SK&F-10047

14198-28-8

2,6-Methano-3-benzazocin-8-ol, 1,2,3,4,5,6-hexahydro-6,11-dimethyl-3-(2-propen-1-yl)-, (2R,6R,11R)-

2,6-Methano-3-benzazocin-8-ol, 1,2,3,4,5,6-hexahydro-6,11-dimethyl-3-(2-propenyl)-, (2R,6R,11R)-

Alazocine

[Wiki]

(1S,9R,13R)-1,13-dimethyl-10-(prop-2-en-1-yl)-10-azatricyclo[7.3.1.02,7]trideca-2,4,6-trien-4-ol

(2r,6r,11r)-6,11-dimethyl-3-prop-2-en-1-yl-1,2,3,4,5,6-hexahydro-2,6-methano-3-benzazocin-8-ol

(−)-SKF 10.047

2,6-Methano-3-benzazocin-8-ol, 1,2,3,4,5,6-hexahydro-6,11-dimethyl-3-(2-propenyl)-, (2R-(2α,6α,11R*))-

3-Allyl-6,11-dimethyl-1,2,3,4,5,6-hexahydro-2,6-methano-benzo[d]azocin-8-ol

58640-81-6

7619-35-4

802564-00-7

l-N-Allylnormetazocine

N-allylnorcyclazocine

N-ALLYLNORMETAZOCINE

OPRD_HUMAN

OPRK_HUMAN

OPRM_HUMAN

SGMR1_CAVPO

SGMR1_HUMAN

SK&F-10047

Δ-type opioid receptor

κ-type opioid receptor

μ-type opioid receptor